Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0682 CHF | +3.96% | -40.95% | +48.26% |
Apr. 30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
Apr. 29 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
Sales 2024 * | - | Sales 2025 * | 20M 22.09M | Capitalization | 8.75M 9.66M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.63M | Net income 2025 * | 13M 14.36M | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 400K | Net cash position 2025 * | 7.23M 7.98M | EV / Sales 2025 * | 0.08 x |
P/E ratio 2024 * |
-0.76
x | P/E ratio 2025 * |
0.32
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.48% |
Latest transcript on Addex Therapeutics Ltd
1 day | +3.96% | ||
1 week | -40.95% | ||
Current month | +11.80% | ||
1 month | -45.44% | ||
3 months | -8.58% | ||
6 months | +31.15% | ||
Current year | +48.26% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.0682 | +3.96% | 841,127 |
24-05-02 | 0.0656 | +7.54% | 465,421 |
24-04-30 | 0.061 | -3.17% | 3,774,330 |
24-04-29 | 0.063 | -45.45% | 11,712,350 |
24-04-26 | 0.1155 | +0.43% | 1,832,556 |
Delayed Quote Swiss Exchange, May 03, 2024 at 11:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.26% | 9.67M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ADXN Stock